다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Neoleukin Therapeutics Inc (NLTX)
Neoleukin Therapeutics Inc (NLTX) 뉴스

NLTX

Neoleukin Therapeutics (NLTX)

Neoleukin Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NLTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/05/10	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/05/07	19:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:34	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:33	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:33	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/23	05:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/03	04:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/19	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/19	05:04	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/08	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/05	08:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/04	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/22	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/21	06:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/15	08:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/15	06:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/15	06:16	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/15	05:08	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/14	23:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/07	06:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	09:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	08:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	08:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	08:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	08:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/01/19	08:45	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc

검색 관련기사 보기:NASDAQ:NLTX

1 2 3 4 5 6 7 8 9 10 다음 >>

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관